Titlebook: Central Nervous System Leukemia; Prevention and Treat Renato Mastrangelo,David G. Poplack,Riccardo Ricca Book 1983 Martinus Nijhoff Publish

傷害

書(shū)目名稱Central Nervous System Leukemia影響因子(影響力)




書(shū)目名稱Central Nervous System Leukemia影響因子(影響力)學(xué)科排名




書(shū)目名稱Central Nervous System Leukemia網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Central Nervous System Leukemia網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Central Nervous System Leukemia被引頻次




書(shū)目名稱Central Nervous System Leukemia被引頻次學(xué)科排名




書(shū)目名稱Central Nervous System Leukemia年度引用




書(shū)目名稱Central Nervous System Leukemia年度引用學(xué)科排名




書(shū)目名稱Central Nervous System Leukemia讀者反饋




書(shū)目名稱Central Nervous System Leukemia讀者反饋學(xué)科排名

chastise

Central Nervous System Prophylaxis for Therapy of Acute Lymphocytic Leukemia,at cure is now a realistic goal of treatment (1). There has been increasing emphasis in recent years, therefore, on the late consequences of the disease and its therapy. These late consequences include possible organ damage, endocrine dysfunction, second malignancies, central nervous system (CNS) dy

富饒

Reduction in Central Nervous System Leukemia with a Pharmaco-kinetically derived Intrathecal-Methot that the primary volume of distribution of IT MTX approximated the extracellular-fluid volume of the central nervous system (CNS) (1). The modified dosage regimen was subsequently confirmed to be less neurotoxic (2), with more consistent cerebrospinal-fluid (CSF) MTX concentrations than dosage base

紀(jì)念

Abduct

,Prophylaxis of Central Nervous System Leukaemia: British Experience, 1970–80, the United Kingdom, one of the variables was ‘prophylactic’ treatment against central nervous system (CNS) leukaemia. In view of the overwhelming evidence for the efficacy of such treatment (1, 2), all patients entered to subsequent trials have received some form of CNS prophylaxis. This report com

evasive

The Norwegian Methotrexate Study in Childhood Acute Lymphocytic Leukemia,elsewhere in this book, have indicated the potential adverse effects of the combination of cranial irradiation and intrathecal methotrexate. Therefore we have tried to avoid prophylactic cranial irradiation in our treatment protocol.

evasive

Therapy Related Central Nervous System Diseases in Children with Acute Lymphocytic Leukemia,nally irradiation to enlarged viscera and mediastinal masses, the majority of children who developed this disease died during the first six months following diagnosis, and rarely did a child survive beyond nine months (1). Farber’s success, reported in 1948, in achieving temporary remissions in five

Prophylaxis

osculate

Evaluation of Adverse Sequelae of Central Nervous System Prophylaxis in Acute Lymphoblastic Leukemin with acute lymphoblastic leukemia. Anatomic abnormalities (defined by CT brain scan), neuroendocrine damage, as well as neurological and intellectual dysfunction have all been reported in patients who have received central nervous system propylaxis, usually in the form of cranial radiation and int

cliche